AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glycigon M OD 60mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Aristo Pharmaceuticals Pvt Ltd

Salt Composition

Gliclazide (60mg) + Metformin (500mg)

Overview Glycigon M OD 60mg/500mg Tablet

Diabetol Duo 60mg/500mg tablets are antidiabetic medications combining two drugs to manage type 2 diabetes in adults. They help regulate blood glucose. Diabetol Duo should be ingested with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may adjust based on blood sugar response. Continue taking this medication even with controlled blood sugar; discontinuation without medical advice risks elevated glucose, potentially causing kidney complications, vision loss, neuropathy, and limb amputation. This medication is part of a comprehensive program including diet, exercise, and weight management as directed by your doctor; lifestyle significantly impacts diabetes control. Common side effects include hypoglycemia (low blood sugar—symptoms include sweating, dizziness, headache, and tremors; always carry fast-acting glucose), constipation, and nausea. Prevent hypoglycemia by maintaining regular meals and carrying glucose sources. Alcohol increases hypoglycemia risk and should be avoided. Other potential side effects are altered taste, diarrhea, abdominal pain, headache, and upper respiratory infections; weight gain may occur. Do not use if you have type 1 diabetes, diabetic ketoacidosis, or severe liver/kidney disease. Inform your physician of any heart condition history before starting treatment; it may be unsuitable. Pregnant or breastfeeding individuals should consult their doctor. Regular blood glucose monitoring and blood tests (for blood cell counts and liver function) may be recommended by your doctor.

Uses of Glycigon M OD 60mg/500mg Tablet

Adult-onset diabetes

Major Benefits of Glycigon M OD 60mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the Glycigon M OD 60mg/500mg tablet whole; avoid chewing, crushing, or fracturing it. Take it with a meal.

Common Side effects of Glycigon M OD 60mg/500mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Glycigon M OD 60mg/500mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing. The Glycigon M OD 60mg/500mg Tablet should be administered with a meal.

How Glycigon M OD 60mg/500mg Tablet works:

Each Glycigon M OD 60mg/500mg tablet combines gliclazide and metformin, two medications used to manage diabetes.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol concurrently with Glycigon M OD 60mg/500mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Glycigon M OD 60mg/500mg tablets is contraindicated during pregnancy due to established fetal risks. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the hazards. Physician consultation is essential.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Lactation and Glycigon M OD 60mg/500mg tablets are likely incompatible. Available data from human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glycigon M OD 60mg/500mg tablets cautiously, potentially requiring dosage modification. Physician consultation is necessary. The medication is contraindicated in those with severe kidney disease. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glycigon M OD 60mg/500mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation should be at a low dose; however, it's contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glycigon M OD 60mg/500mg Tablet :

Should you forget to take your Glycigon M OD 60mg/500mg Tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Glycigon M OD 60mg/500mg Tablet

LabelValue
Potential for Dependence None.
Type of Treatment Medication for diabetes

FAQs on Glycigon M OD 60mg/500mg Tablet

Glycigon M OD 60mg/500mg tablets contain gliclazide and metformin, acting together to manage type 2 diabetes mellitus in adults. This medication helps regulate blood sugar when used alongside a healthy diet and regular physical activity. Gliclazide enhances insulin secretion from the pancreas, while metformin reduces hepatic glucose production and improves insulin responsiveness. This combination therapy is unsuitable for type 1 diabetes.
Glycigon M OD 60mg/500mg tablets may cause common adverse reactions such as low blood sugar (hypoglycemia), altered taste perception, nausea, abdominal discomfort, diarrhea, headache, and upper respiratory infections. Infrequently, serious side effects, including lactic acidosis, may occur. Prolonged use can result in vitamin B12 deficiency.
Indeed, Glycigon M OD 60mg/500mg Tablets may induce hypoglycemia. Manifestations of low blood sugar include nausea, headache, irritability, increased hunger, sweating, vertigo, tachycardia, and feelings of anxiety or tremor. The likelihood increases with skipped or delayed meals, alcohol consumption, strenuous physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Always carry a readily available source of glucose, such as glucose tablets, honey, or fruit juice.
Glycigon M OD 60mg/500mg Tablets can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this is an uncommon adverse reaction to metformin. Risk factors include pre-existing kidney impairment, advanced age, and significant alcohol consumption. Symptoms may present as muscle aches or weakness, lightheadedness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal discomfort, or bradycardia. If these symptoms occur, discontinue Glycigon M OD 60mg/500mg Tablet use and seek immediate medical attention.
Prolonged Glycigon M OD 60mg/500mg Tablet use can indeed lead to vitamin B12 deficiency. This is because the medication impedes the stomach's absorption of vitamin B12. Untreated deficiency can manifest as anemia, neurological issues including tingling and numbness in extremities, muscle weakness, urinary dysfunction, cognitive changes, and gait instability. To mitigate these risks, supplemental vitamin B12 intake, at a minimum of once annually, is recommended by some studies.
Patients with hypersensitivity to Glycigon M OD 60mg/500mg Tablet constituents or inactive ingredients should not use this medication. Its use is contraindicated in individuals with moderate to severe renal impairment or pre-existing metabolic acidosis, such as diabetic ketoacidosis.
Consuming alcohol while taking Glycigon M OD 60mg/500mg tablets is unsafe. This combination can lead to dangerously low blood sugar and a heightened risk of lactic acidosis.
Glycigon M OD 60mg/500mg tablets contain gliclazide and metformin, employed to manage type 2 diabetes mellitus in adults. This dual-action medication enhances glycemic control when coupled with a balanced diet and physical activity. Gliclazide stimulates pancreatic insulin secretion, while metformin reduces hepatic glucose output and increases insulin responsiveness. This formulation is unsuitable for type 1 diabetes management.
Glycigon M OD 60mg/500mg tablets may cause frequent adverse reactions such as low blood sugar, taste disturbances, nausea, abdominal discomfort, loose stools, headache, and upper respiratory infections. Rare but potentially severe complications, including lactic acidosis, are also possible. Prolonged therapy may result in vitamin B12 depletion.
Indeed, Glycigon M OD 60mg/500mg Tablets may induce hypoglycemia. Low blood sugar can manifest as nausea, headache, irritability, hunger pangs, sweating, vertigo, tachycardia, and feelings of anxiety or tremors. The risk increases with skipped or delayed meals, alcohol consumption, strenuous physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying readily available glucose sources, such as glucose tablets, honey, or fruit juice, is advisable.
Glycigon M OD 60mg/500mg Tablets can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this is an infrequent complication of metformin use. Risk factors include pre-existing kidney impairment, advanced age, and significant alcohol consumption. Lactic acidosis symptoms might present as muscle aches or weakness, lightheadedness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal discomfort, or a slow pulse. Should these symptoms appear, discontinue Glycigon M OD 60mg/500mg Tablet use and seek immediate medical attention.
Prolonged Glycigon M OD 60mg/500mg Tablet use can indeed lead to vitamin B12 deficiency. This arises from the medication's impact on gastric vitamin B12 absorption. Untreated deficiency may result in anemia, neurological complications such as peripheral neuropathy (manifesting as tingling, numbness in extremities, and weakness), urinary dysfunction, cognitive changes, and ataxia. To mitigate these risks, supplemental vitamin B12 intake, at a minimum of annually, is recommended by some studies.
Patients with hypersensitivity to any Glycigon M OD 60mg/500mg Tablet ingredient or excipient should not use this medication. Its use is contraindicated in individuals with moderate to severe renal impairment or pre-existing metabolic acidosis, such as diabetic ketoacidosis.
Combining Glycigon M OD 60mg/500mg tablets with alcohol is unsafe. This combination risks dangerously low blood sugar (hypoglycemia) and raises the likelihood of lactic acidosis.
Glycigon M OD 60mg/500mg ...
44
MRP 53
17% off